Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+Mozilla Firefox 20+Internet Explorer 11Opera 15–18Apple Safari 7SeaMonkey 2.15-2.23

ELCC 2017

The European Lung Cancer Conference is organised by top academic experts in lung cancer and thoracic malignancies.

The conference is relevant for medical oncologists, radiation oncologists, thoracic surgeons, respiratory physicians, and other medical professionals involved in the diagnosis, treatment and follow-up of patients with lung cancer.

Access the ELCC 2017 Online Programme Download the Programme (PDF)

Conference objectives

  • To advance the quality of lung cancer treatment by providing regular updates to lung cancer and other thoracic oncology specialists on different multidisciplinary topics important for clinical practice
  • To discuss the increasing understanding of molecular biology and immunology of lung tumours and how it changes the diagnostic and treatment landscape
  • To present the latest advances in translational and clinical research in different settings across lung and other thoracic malignancies

Main themes 2017

  • New IASLC Staging
  • ESMO recommendations for thoracic malignancies
  • Immunotherapy: first-line treatment, biomarkers and combination approaches
  • New steps in the treatment of molecularly defined NSCLC
  • SCLC and mesothelioma
  • Management and diagnosis of persistence in molecularly defined NSCLC
  • Management of brain metastases

Target Audience

  • Medical oncologists
  • Radiation oncologists
  • Thoracic surgeons
  • Respiratory physicians / Pneumologists
  • Interventional radiologists
  • Pathologists


ESMO-MORA: The Conference programme has been accredited with 25 ESMO-MORA category 1 points. Recertification is necessary for medical oncologists to remain professionally certified by ESMO. It also guarantees that a certified medical oncologist has continued to update her/his knowledge and still possess the necessary skills and standards for the practice of medical oncology. See here for further details.

CME: The ELCC 2017 programme is accredited by the European Accreditation Council for Continuing Medical Education (EACCME) to provide the following CME activity for medical specialists. The EACCME is an institution of the European Union of Medical Specialists (UEMS), www.uems.net. The Conference programme is designated for a maximum of 18 hours of European external CME credits. Through an agreement between the European Union of Medical Specialists and the American Medical Association, physicians may convert EACCME credits to an equivalent number of AMA PRA Category 1 Credits™Information on the process to convert EACCME credit to AMA credit can be found online here. Live educational activities, occurring outside of Canada, recognised by the UEMS-EACCME for ECMEC credits are deemed to be Accredited Group Learning Activities (Section 1) as defined by the Maintenance of Certification Program of The Royal College of Physicians and Surgeons of Canada. ACCME credit system is based on 1 ECMEC per hour with a maximum of 3 ECMECs for half a day and 6 ECMECs for a full-day event.


The conference webcasts will include all the session of the official programme, where speaker permission is granted, and will be available on this website and OncologyPRO for ESMO members.

This site uses cookies. Some of these cookies are essential, while others help us improve your experience by providing insights into how the site is being used.

For more detailed information on the cookies we use, please check our Privacy Policy.

Customise settings